T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract

Immunologic Research

Volumn 50, Issue 2-3, 2011, Pages 269-275

  Lu, Binfeng ^a   Chen, Lujun ^b   Liu, Lin ^a   Zhu, Yibei ^b   Wu, Changping ^c   Jiang, Jingting ^c   Zhang, Xueguang ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

B7 family; CD8+ T cell; Co inhibitory molecule; T bet; Tumor immunosurveillance; Tumor infiltrating lymphocyte

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; EOMESODERMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; TUMOR VACCINE; VASCULOTROPIN RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CANCER TISSUE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL METABOLISM; CELL MIGRATION; CELLULAR IMMUNITY; DIGESTIVE SYSTEM CANCER; ENZYME ACTIVATION; ESOPHAGUS CANCER; GLIOBLASTOMA; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSURVEILLANCE; IN VIVO STUDY; INFLAMMATORY CELL; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STOMACH CANCER; SURVIVAL TIME; T LYMPHOCYTE; TH1 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR VOLUME; UPPER GASTROINTESTINAL TRACT; UPREGULATION; VACCINATION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD80; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASMS; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT; UPPER GASTROINTESTINAL TRACT;

EID: 79961167936     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-011-8227-9     Document Type: Article

References (63)

1. A Jemal F Bray MM Center J Ferlay E Ward D Forman 2011 Global cancer statistics CA Cancer J Clin 61 69 90 21296855 10.3322/caac.20107
2. DJ Cohen J Ajani 2011 An expert opinion on esophageal cancer therapy Expert Opin Pharmacother 12 225 239 21226634 10.1517/14656566.2010.517748
3. J Lagergren P Lagergren 2010 Oesophageal cancer BMJ 341 c6280 21112905 10.1136/bmj.c6280
4. OJ Finn 2008 Cancer immunology N Engl J Med 358 2704 2715 18565863 10.1056/NEJMra072739 1:CAS:528:DC%2BD1cXns1ajt7k%3D (Pubitemid 351860863)
5. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecnik C Lagorce-Pages M Tosolini M Camus A Berger P Wind F Zinzindohoue P Bruneval PH Cugnenc Z Trajanoski WH Fridman F Pages 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 1960 1964 17008531 10.1126/science.1129139 1:CAS:528:DC%2BD28XhtVSnsrnK (Pubitemid 44498003)
6. W Zou 2005 Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat Rev Cancer 5 263 274 15776005 10.1038/nrc1586 1:CAS:528:DC%2BD2MXivVars7g%3D (Pubitemid 40488632)
7. W Zou 2006 Regulatory T cells, tumour immunity and immunotherapy Nat Rev Immunol 6 295 307 16557261 10.1038/nri1806 1:CAS:528:DC%2BD28XivVyru7k%3D
8. W Zou L Chen 2008 Inhibitory B7-family molecules in the tumour microenvironment Nat Rev Immunol 8 467 477 18500231 10.1038/nri2326 1:CAS:528:DC%2BD1cXmt1Ojt74%3D (Pubitemid 351733418)
9. RJ Greenwald GJ Freeman AH Sharpe 2005 The B7 family revisited Annu Rev Immunol 23 515 548 15771580 10.1146/annurev.immunol.23.021704.115611 (Pubitemid 40563179)
10. G Driessens J Kline TF Gajewski 2009 Costimulatory and coinhibitory receptors in anti-tumor immunity Immunol Rev 229 126 144 19426219 10.1111/j.1600-065X.2009.00771.x 1:CAS:528:DC%2BD1MXhsFGls7jE
11. X Zang JP Allison 2007 The B7 family and cancer therapy: costimulation and coinhibition Clin Cancer Res 13 5271 5279 17875755 10.1158/1078-0432.CCR-07- 1030 1:CAS:528:DC%2BD2sXhtVCitL7L (Pubitemid 47510350)
12. N Martin-Orozco C Dong 2007 Inhibitory costimulation and anti-tumor immunity Semin Cancer Biol 17 288 298 17683946 10.1016/j.semcancer.2007.06.003 1:CAS:528:DC%2BD2sXovFyjs7s%3D (Pubitemid 47211965)
13. TF Gajewski Y Meng C Blank I Brown A Kacha J Kline H Harlin 2006 Immune resistance orchestrated by the tumor microenvironment Immunol Rev 213 131 145 16972901 10.1111/j.1600-065X.2006.00442.x 1:CAS:528:DC%2BD28XhtF2lsrbL (Pubitemid 44401498)
14. J Jiang Y Zhu C Wu Y Shen W Wei L Chen X Zheng J Sun B Lu X Zhang 2010 Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer Cancer Immunol Immunother 59 1707 1714 20725832 10.1007/s00262-010-0900-7 1:CAS:528:DC%2BC3cXhtVyrtrrK
15. LJ Chen J Sun HY Wu SM Zhou Y Tan M Tan BE Shan BF Lu XG Zhang 2011 B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma Cancer Immunol Immunother 26 26
16. S Ju Y Zhu L Liu S Dai C Li E Chen Y He X Zhang B Lu 2009 Gadd45b and Gadd45g are important for anti-tumor immune responses Eur J Immunol 39 3010 3018 19688743 10.1002/eji.200839154 1:CAS:528:DC%2BD1MXhsFWhtbnO
17. Y Zhu S Ju E Chen S Dai C Li P Morel L Liu X Zhang B Lu 2010 T-bet and eomesodermin are required for T cell-mediated antitumor immune responses J Immunol 185 3174 3183 20713880 10.4049/jimmunol.1000749 1:CAS:528: DC%2BC3cXhtFSntL7L
18. JC Underwood 1974 Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review Br J Cancer 30 538 548 4614858 10.1038/bjc.1974.233 1:STN:280:DyaE2M%2FptVyqsQ%3D%3D
19. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet 357 539 545 11229684 10.1016/S0140-6736(00)04046-0 1:CAS:528: DC%2BD3MXhsVKltb0%3D (Pubitemid 32173595)
20. LH Glimcher 2007 Trawling for treasure: tales of T-bet Nat Immunol 8 448 450 17440449 10.1038/ni0507-448 1:CAS:528:DC%2BD2sXkt1Khs7k%3D (Pubitemid 46605908)
21. MB Werneck G Lugo-Villarino ES Hwang H Cantor LH Glimcher 2008 T-bet plays a key role in NK-mediated control of melanoma metastatic disease J Immunol 180 8004 8010 18523263 1:CAS:528:DC%2BD1cXntVelsr4%3D
22. WS Garrett S Punit CA Gallini M Michaud D Zhang KS Sigrist GM Lord JN Glickman LH Glimcher 2009 Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells Cancer Cell 16 208 219 19732721 10.1016/j.ccr.2009.07.015 1:CAS:528:DC%2BD1MXhsVChs7vP
23. MW Lipscomb L Chen JL Taylor C Goldbach SC Watkins P Kalinski LH Butterfield AK Wesa WJ Storkus 2009 Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro J Immunol 183 7250 7258 19915058 10.4049/jimmunol.0901477 1:CAS:528:DC%2BD1MXhsVehsbnK
24. Y Qu L Chen AD Pardee JL Taylor AK Wesa WJ Storkus 2010 Intralesional delivery of dendritic cells engineered to express T-bet promotes protective type 1 immunity and the normalization of the tumor microenvironment J Immunol 185 2895 2902 20675595 10.4049/jimmunol.1001294 1:CAS:528:DC%2BC3cXhtVCntbvK
25. EL Pearce AC Mullen GA Martins CM Krawczyk AS Hutchins VP Zediak M Banica CB DiCioccio DA Gross CA Mao H Shen N Cereb SY Yang T Lindsten J Rossant CA Hunter SL Reiner 2003 Control of effector CD8+ T cell function by the transcription factor eomesodermin Science 302 1041 1043 14605368 10.1126/science.1090148 1:CAS:528:DC%2BD3sXos1CmsLc%3D (Pubitemid 37386196)
26. K Lee HJ Min EJ Jang JH Hong ES Hwang 2010 In vivo tumor suppression activity by T cell-specific T-bet restoration Int J Cancer 127 2129 2137 20143391 10.1002/ijc.25238 1:CAS:528:DC%2BC3cXhtFSisrnL
27. JR Groom AD Luster 2011 CXCR3 ligands: redundant, collaborative and antagonistic functions Immunol Cell Biol 89 207 215 21221121 10.1038/icb.2010.158 1:CAS:528:DC%2BC3MXitVCls7s%3D
28. W Zou NP Restifo CS Hinrichs A Kaiser CM Paulos L Cassard L Sanchez-Perez B Heemskerk C Wrzesinski ZA Borman P Muranski 2010 T(H)17 cells in tumour immunity and immunotherapy type 17 CD8+ T cells display enhanced antitumor immunity Nat Rev Immunol 10 248 256 20336152 10.1038/nri2742 1:CAS:528:DC%2BC3cXjvVGlt7k%3D
29. W Zou NP Restifo 2010 T(H)17 cells in tumour immunity and immunotherapy Nat Rev Immunol 10 248 256 20336152 10.1038/nri2742 1:CAS:528: DC%2BC3cXjvVGlt7k%3D
30. M Ishida Y Iwai Y Tanaka T Okazaki GJ Freeman N Minato T Honjo 2002 Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues Immunol Lett 84 57 62 12161284 10.1016/S0165-2478(02)00142-6 1:CAS:528:DC%2BD38XlvVersr4%3D (Pubitemid 34879920)
31. Y Latchman CR Wood T Chernova D Chaudhary M Borde I Chernova Y Iwai AJ Long JA Brown R Nunes EA Greenfield K Bourque VA Boussiotis LL Carter BM Carreno N Malenkovich H Nishimura T Okazaki T Honjo AH Sharpe GJ Freeman 2001 PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat Immunol 2 261 268 11224527 10.1038/85330 1:CAS:528:DC%2BD3MXhvVaksrc%3D (Pubitemid 33706004)
32. GJ Freeman AJ Long Y Iwai K Bourque T Chernova H Nishimura LJ Fitz N Malenkovich T Okazaki MC Byrne HF Horton L Fouser L Carter V Ling MR Bowman BM Carreno M Collins CR Wood T Honjo 2000 Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J Exp Med 192 1027 1034 11015443 10.1084/jem.192.7.1027 1:CAS:528:DC%2BD3cXntFSlt7o%3D
33. JL Riley 2009 PD-1 signaling in primary T cells Immunol Rev 229 114 125 19426218 10.1111/j.1600-065X.2009.00767.x 1:CAS:528:DC%2BD1MXhsFGls7jL
34. SE Sandner MR Clarkson AD Salama A Sanchez-Fueyo C Domenig A Habicht N Najafian H Yagita M Azuma LA Turka MH Sayegh 2005 Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo J Immunol 174 3408 3415 15749874 1:CAS:528:DC%2BD2MXitVehsLo%3D (Pubitemid 40354046)
35. H Dong G Zhu K Tamada DB Flies JM van Deursen L Chen 2004 B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes Immunity 20 327 336 15030776 10.1016/S1074-7613(04)00050-0 1:CAS:528: DC%2BD2cXis1Kht7w%3D (Pubitemid 38388234)
36. H Dong SE Strome DR Salomao H Tamura F Hirano DB Flies PC Roche J Lu G Zhu K Tamada VA Lennon E Celis L Chen 2002 Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 793 800 12091876 1:CAS:528:DC%2BD38Xls12msLo%3D
37. A Sabapatha C Gercel-Taylor DD Taylor 2006 Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences Am J Reprod Immunol 56 345 355 17076679 10.1111/j.1600-0897.2006.00435.x 1:CAS:528:DC%2BD28XhtlCjtbfF (Pubitemid 44669331)
38. JA Brown DM Dorfman FR Ma EL Sullivan O Munoz CR Wood EA Greenfield GJ Freeman 2003 Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production J Immunol 170 1257 1266 12538684 1:CAS:528:DC%2BD3sXnvVOmtQ%3D%3D (Pubitemid 36139491)
39. PS Kim R Ahmed 2010 Features of responding T cells in cancer and chronic infection Curr Opin Immunol 22 223 230 20207527 10.1016/j.coi.2010.02.005 1:CAS:528:DC%2BC3cXks1Srsbc%3D
40. H Shin EJ Wherry 2007 CD8 T cell dysfunction during chronic viral infection Curr Opin Immunol 19 408 415 17656078 10.1016/j.coi.2007.06.004 1:CAS:528:DC%2BD2sXpsFKktrk%3D (Pubitemid 47284857)
41. AJ Zajac JN Blattman K Murali-Krishna DJ Sourdive M Suresh JD Altman R Ahmed 1998 Viral immune evasion due to persistence of activated T cells without effector function J Exp Med 188 2205 2213 9858507 10.1084/jem.188.12.2205 1:CAS:528:DyaK1MXhtFaqsg%3D%3D (Pubitemid 29028493)
42. CL Day DE Kaufmann P Kiepiela JA Brown ES Moodley S Reddy EW Mackey JD Miller AJ Leslie C DePierres Z Mncube J Duraiswamy B Zhu Q Eichbaum M Altfeld EJ Wherry HM Coovadia PJ Goulder P Klenerman R Ahmed GJ Freeman BD Walker 2006 PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression Nature 443 350 354 16921384 10.1038/nature05115 1:CAS:528:DC%2BD28Xpslaksrc%3D (Pubitemid 44435155)
43. S Urbani B Amadei D Tola M Massari S Schivazappa G Missale C Ferrari 2006 PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion J Virol 80 11398 11403 16956940 10.1128/JVI.01177-06 1:CAS:528:DC%2BD28Xht1KhurbM (Pubitemid 44706581)
44. EJ Wherry SJ Ha SM Kaech WN Haining S Sarkar V Kalia S Subramaniam JN Blattman DL Barber R Ahmed 2007 Molecular signature of CD8+ T cell exhaustion during chronic viral infection Immunity 27 670 684 17950003 10.1016/j.immuni. 2007.09.006 1:CAS:528:DC%2BD2sXht1ygurzE (Pubitemid 47615511)
45. AT Parsa JS Waldron A Panner CA Crane IF Parney JJ Barry KE Cachola JC Murray T Tihan MC Jensen PS Mischel D Stokoe RO Pieper 2007 Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma Nat Med 13 84 88 17159987 10.1038/nm1517 1:CAS:528:DC%2BD2sXhvFWjtQ%3D%3D (Pubitemid 46067390)
46. BD Manning LC Cantley 2007 AKT/PKB signaling: navigating downstream Cell 129 1261 1274 17604717 10.1016/j.cell.2007.06.009 1:CAS:528:DC%2BD2sXotV2hs7g%3D (Pubitemid 46962095)
47. MA Hildebrandt H Yang MC Hung JG Izzo M Huang J Lin JA Ajani X Wu 2009 Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy J Clin Oncol 27 857 871 19164214 10.1200/JCO.2008.17.6297 1:CAS:528: DC%2BD1MXjs1Kntro%3D
48. C Wu Y Zhu J Jiang J Zhao XG Zhang N Xu 2006 Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance Acta Histochem 108 19 24 16530813 10.1016/j.acthis.2006. 01.003 (Pubitemid 44316588)
49. J Sun K Xu C Wu Y Wang Y Hu Y Zhu Y Chen Q Shi G Yu X Zhang 2007 PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies Tiss Antigens 69 19 27 10.1111/j.1399-0039.2006.00701.x 1:CAS:528:DC%2BD2sXitV2jsLc%3D (Pubitemid 46025335)
50. Y Ohigashi M Sho Y Yamada Y Tsurui K Hamada N Ikeda T Mizuno R Yoriki H Kashizuka K Yane F Tsushima N Otsuki H Yagita M Azuma Y Nakajima 2005 Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer Clin Cancer Res 11 2947 2953 15837746 10.1158/1078-0432.CCR-04-1469 1:CAS:528:DC%2BD2MXjtlejt7k%3D (Pubitemid 40525197)
51. DV Prasad S Richards XM Mai C Dong 2003 B7S1: a novel B7 family member that negatively regulates T cell activation Immunity 18 863 873 12818166 10.1016/S1074-7613(03)00147-X 1:CAS:528:DC%2BD3sXltFals7o%3D (Pubitemid 36776433)
52. GL Sica IH Choi G Zhu K Tamada SD Wang H Tamura AI Chapoval DB Flies L Bajorath L Chen 2003 B7-H4: a molecule of the B7 family, negatively regulates T cell immunity Immunity 18 849 861 12818165 10.1016/S1074-7613(03)00152-3 1:CAS:528:DC%2BD3sXltFals70%3D (Pubitemid 36776432)
53. X Zang P Loke J Kim K Murphy R Waitz JP Allison 2003 B7×: a widely expressed B7 family member that inhibits T cell activation Proc Natl Acad Sci USA 100 10388 10392 12920180 10.1073/pnas.1434299100 1:CAS:528: DC%2BD3sXntFynsrg%3D (Pubitemid 37071888)
54. WK Suh S Wang GS Duncan Y Miyazaki E Cates T Walker BU Gajewska E Deenick W Dawicki H Okada A Wakeham A Itie TH Watts PS Ohashi M Jordana H Yoshida TW Mak 2006 Generation and characterization of B7-H4/B7S1/B7×-deficient mice Mol Cell Biol 26 6403 6411 16914726 10.1128/MCB.00755-06 1:CAS:528: DC%2BD28XovFyhu74%3D (Pubitemid 44277881)
55. G Zhu MM Augustine T Azuma L Luo S Yao S Anand AC Rietz J Huang H Xu AS Flies SJ Flies K Tamada M Colonna JM van Deursen L Chen 2009 B7-H4-deficient mice display augmented neutrophil-mediated innate immunity Blood 113 1759 1767 19109567 10.1182/blood-2008-01-133223 1:CAS:528:DC%2BD1MXisV2iu7c%3D
56. S Salceda T Tang M Kmet A Munteanu M Ghosh R Macina W Liu G Pilkington J Papkoff 2005 The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation Exp Cell Res 306 128 141 15878339 10.1016/j.yexcr.2005.01.018 1:CAS:528:DC%2BD2MXjvVOht7k%3D (Pubitemid 40692778)
57. I Kryczek L Zou P Rodriguez G Zhu S Wei P Mottram M Brumlik P Cheng T Curiel L Myers A Lackner X Alvarez A Ochoa L Chen W Zou 2006 B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma J Exp Med 203 871 881 16606666 10.1084/jem.20050930 1:CAS:528: DC%2BD28Xjsl2is74%3D
58. H Yu D Pardoll R Jove 2009 STATs in cancer inflammation and immunity: a leading role for STAT3 Nat Rev Cancer 9 798 809 19851315 10.1038/nrc2734 1:CAS:528:DC%2BD1MXhtlSjur%2FP
59. K Sakuishi L Apetoh JM Sullivan BR Blazar VK Kuchroo AC Anderson 2010 Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity J Exp Med 207 2187 2194 20819927 10.1084/jem.20100643 1:CAS:528:DC%2BC3cXht1Cms73O
60. J Fourcade Z Sun M Benallaoua P Guillaume IF Luescher C Sander JM Kirkwood V Kuchroo HM Zarour 2010 Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients J Exp Med 207 2175 2186 20819923 10.1084/jem.20100637 1:CAS:528:DC%2BC3cXht1Cms73N
61. RA Cairns IS Harris TW Mak 2011 Regulation of cancer cell metabolism Nat Rev Cancer 11 85 95 21258394 10.1038/nrc2981 1:CAS:528:DC%2BC3MXps1ahuw%3D%3D
62. KA Frauwirth JL Riley MH Harris RV Parry JC Rathmell DR Plas RL Elstrom CH June CB Thompson 2002 The CD28 signaling pathway regulates glucose metabolism Immunity 16 769 777 12121659 10.1016/S1074-7613(02)00323-0 1:CAS:528: DC%2BD38XltF2gtbo%3D (Pubitemid 34786476)
63. MA Koch G Tucker-Heard NR Perdue JR Killebrew KB Urdahl DJ Campbell 2009 The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation Nat Immunol 10 595 602 19412181 10.1038/ni.1731 1:CAS:528:DC%2BD1MXltlSrsbY%3D